Follow
Carcinoma
Carcinoma: is a type of cancer that starts in cells that make up the skin or the tissue lining organs, such as the liver or kidneys. Like other types of cancer, carcinomas are abnormal cells that divide without control. They are able to spread to other parts of the body, but don't always.
What's Popular in Carcinoma
-
FEB 22, 2024Clinical & Molecular DX
A new tool has been developed to detect skin cancer; it utilizes a biosensor that can identify small changes in the char ...Written By: Carmen LeitchFEB 21, 2024Cancer
Last August, Labroots covered the decision of the National Health Service of England (NHS England) to allow subcu ...Written By: Katie KokolusFEB 19, 2024Cancer
Georgios Nikolaou Papanikolaou and Andromache Mavroyeni married in Athens on September 25, 1910. No, this is not t ...Written By: Katie KokolusJAN 11, 2024Cancer
A commonly used biopsy technique, known as a percutaneous or needle biopsy, involves inserting a small needle under the ...Written By: Katie KokolusJAN 04, 2024Cancer
The most common type of adult liver cancer, hepatocellular carcinoma (HCC), accounts for about 90% of liver cancer diagn ...Written By: Katie Kokolus
FEB 22, 2024
Clinical & Molecular DX
A new tool has been developed to detect skin cancer; it utilizes a biosensor that can identify small changes in the char
...
Written By:
Carmen Leitch
FEB 21, 2024
Cancer
Last August, Labroots covered the decision of the National Health Service of England (NHS England) to allow subcu
...
Written By:
Katie Kokolus
FEB 19, 2024
Cancer
Georgios Nikolaou Papanikolaou and Andromache Mavroyeni married in Athens on September 25, 1910. No, this is not t
...
Written By:
Katie Kokolus
JAN 11, 2024
Cancer
A commonly used biopsy technique, known as a percutaneous or needle biopsy, involves inserting a small needle under the
...
Written By:
Katie Kokolus
JAN 04, 2024
Cancer
The most common type of adult liver cancer, hepatocellular carcinoma (HCC), accounts for about 90% of liver cancer diagn
...
Written By:
Katie Kokolus
NOV 16, 2023
Immunology
Cancer is very difficult to treat due to various components that therapies must address to effectively kill or lyse tumo
...
Written By:
Brian G. Morreale
OCT 31, 2023
Cancer
Today, we celebrate Halloween, a holiday originating from the ancient Celtic festival of Samhain. Some 2,000 years
...
Written By:
Katie Kokolus
OCT 17, 2023
Cancer
Cutaneous squamous cell carcinoma (cSCC) is a common form of skin cancer often caused by chronic exposure to ultraviolet
...
Written By:
Greta Anne
OCT 05, 2023
Cancer
“Cancer” is not a word we want to hear. Conversations with your doctor about cancer can induce fear, a
...
Written By:
Katie Kokolus
-
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...Speaker: Dr. Eloisa Jantus Lewintre, PhD , Dr. Gorka Alkorta-Aranburu , Matteo Allegretti, PhDPresented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher ScientificSeptember 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...Speaker: Dr. Eloisa Jantus Lewintre, PhD , Dr. Gorka Alkorta-Aranburu , Matteo Allegretti, PhDPresented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher ScientificSeptember 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...Speaker: Dr. Eloisa Jantus Lewintre, PhD , Dr. Gorka Alkorta-Aranburu , Matteo Allegretti, PhDPresented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher ScientificJUL 18, 2023 3:30 PM EDT
The practice of pathology is rapidly undergoing a transformation in which multiple tools such as digital imaging, advanced artificial intelligence algorithms, and computer-aided diagnostic t...
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
September 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
September 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
Speaker:
Dr. Eloisa Jantus Lewintre, PhD
, Dr. Gorka Alkorta-Aranburu
, Matteo Allegretti, PhD
Presented at: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
JUL 18, 2023 3:30 PM EDT
The practice of pathology is rapidly undergoing a transformation in which multiple tools such as digital imaging, advanced artificial intelligence algorithms, and computer-aided diagnostic t...
July 18, 2023 12:30PM EDT
Lung cancer is still responsible for most cancer-related deaths for both genders in the United States. Traditionally, diagnosis and management of patients has been based on tissue biopsy to...
MAR 16, 2023 | 9:00 AM
Date: March 16, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Problem Screening greater than 10 pathogens or SNPs in a sample is challenging due to limitations in fluorescence colo...
SEP 21, 2022 | 10:00 AM
Date: September 21, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) This talk aims to describe a popular workflow that profiles specific brain cell types in healthy and diseased post-m...
AUG 24, 2021 | 8:00 AM
Date: August 24, 2021 Time: 8:00am (PST), 11:00am (EST) Liver cancer is the third cause of cancer-related mortality worldwide. Most patients have chronic liver disease, which has allowed...
-
JUN 12, 2024 | 1:00 PM PDTC.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...JAN 31, 2023 | 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...JUN 22, 2022 | 3:00 AM PDT
Please join us for Ion World 2022, a virtual conference that will provide an opportunity to hear from scientists around the world, on how they are advancing research in a broad range of appl...SEP 14, 2021 | 7:00 AM PDT
Working in Tandem : 1st annual TMT Symposia Tandem Mass Tags (TMT) are isobaric labels that allow for simultaneous identification and quantification of protein expression from multiple sampl...SEP 14, 2021 | 12:00 AM PDT
Europe - 9:00 AM Central European Summer Time Americas - 9:00 AM Central Daylight Time Asia-Pacific - 9:00 AM Beijing Standard Time (*September 15) ADVANCING SCIENCE: A VIRTUAL IMMUNOLOGY CO...
JUN 12, 2024
| 1:00 PM PDT
C.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
JAN 31, 2023
| 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
JUN 22, 2022
| 3:00 AM PDT
Please join us for Ion World 2022, a virtual conference that will provide an opportunity to hear from scientists around the world, on how they are advancing research in a broad range of appl...
SEP 14, 2021
| 7:00 AM PDT
Working in Tandem : 1st annual TMT Symposia Tandem Mass Tags (TMT) are isobaric labels that allow for simultaneous identification and quantification of protein expression from multiple sampl...
SEP 14, 2021
| 12:00 AM PDT
Europe - 9:00 AM Central European Summer Time Americas - 9:00 AM Central Daylight Time Asia-Pacific - 9:00 AM Beijing Standard Time (*September 15) ADVANCING SCIENCE: A VIRTUAL IMMUNOLOGY CO...
SEP 08, 2021
| 6:00 AM PDT
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
Western blot analysis is a method widely used in the lab today because of its versatility in detecting and measuring specific target proteins in a sample. However, in recent years the reprod...
Each step in a diagnostic test's journey-from raw material extraction to patient administration-can influence outcomes....
10/14-15 9am-1pm CDT
Coming to you from a safe, physical distance, 2020 Abbott World Summit. This event will feature over 15 global experts sharing their latest discoveries and experiences in cancer screening, r...